Ra Capital Management, L.P.

Insider Reports History

Location
200 Berkeley Street, 18 Th Floor, Boston, MA
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ra Capital Management, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cidara Therapeutics, Inc. Director, 10%+ Owner Common Stock 3.37M $148M $44.00 Jun 26, 2025 Indirect
Mineralys Therapeutics, Inc. Director Common Stock 5.46M $139M $25.50 Sep 4, 2025 Indirect
Cytek Biosciences, Inc. Director, 10%+ Owner Common Stock 13.4M $127M $9.50 Mar 15, 2022 Indirect
Wave Life Sciences Ltd. Director, 10%+ Owner Ordinary Shares 18.2M $122M $6.69 Nov 13, 2025 Indirect
iTeos Therapeutics, Inc. Former 10% Owner Pre- Funded Warrants (Right to Buy) 6.61M $116M $17.50 May 12, 2024 Indirect
Tyra Biosciences, Inc. Director, 10%+ Owner Common Stock 10.3M $104M $10.13 Jun 16, 2025 Indirect
Fulcrum Therapeutics, Inc. 10%+ Owner Common Stock 10.2M $79.4M $7.76 Sep 12, 2024 Indirect
4D Molecular Therapeutics, Inc. 10%+ Owner Common Stock 4.56M $74.5M $16.33 Dec 9, 2024 Indirect
PepGen Inc. Director, 10%+ Owner Common Stock 18.6M $59.4M $3.20 Sep 26, 2025 Indirect
Vor Biopharma Inc. Director, 10%+ Owner Pre-Funded Warrant (Right to Buy) 10M $50M $5.00 Sep 18, 2025 Indirect
Kala Pharmaceuticals, Inc. 10%+ Owner Common Stock 7.04M $47.4M $6.74 May 26, 2022 Indirect
89bio, Inc. Director, 10%+ Owner Pre-Funded Warrants (Right to Buy) 0 $36.8M $8.50 Oct 30, 2025 Indirect
Bicara Therapeutics Inc. Director, 10%+ Owner Common Stock 2.65M $35.1M $13.24 Sep 16, 2024 Indirect
Enliven Therapeutics, Inc. Former 10% owner Common Stock 2.12M $32.1M $15.14 Feb 23, 2023 Indirect
iTeos Therapeutics, Inc. Former 10% Owner Common Stock 2.55M $21.3M $8.37 May 12, 2024 Indirect
Vor Biopharma Inc. Director, 10%+ Owner Common Stock 780K $19.6M $25.12 Oct 30, 2025 Indirect
Cidara Therapeutics, Inc. Director, 10%+ Owner Pre-Funded Warrants (Right to Buy) 1.29M $19.2M $14.91 Nov 26, 2024 Indirect
Solid Biosciences Inc. 10%+ Owner Pre-Funded Warrants (Right to Buy) 3.72M $15M $4.03 Feb 19, 2025 Indirect
Therapeutics Acquisition Corp. Director Common Stock 1.1M $13.7M $12.45 Jun 29, 2021 Indirect
Tyra Biosciences, Inc. Director, 10%+ Owner Pre-Funded Warrants (Right to Buy) 1M $13M $13.01 Oct 18, 2024 Indirect
Eliem Therapeutics, Inc. Director, 10%+ Owner Common Stock 2.87M $11M $3.84 Jun 27, 2024 Indirect
RxSight, Inc. 10%+ Owner Common Stock 214K $10.3M $48.00 Aug 3, 2021 Indirect
Black Diamond Therapeutics, Inc. Director Common Stock 3.21M $8.77M $2.73 Jul 5, 2023 Indirect
Septerna, Inc. Director, 10%+ Owner Common Stock 1.47M $8.61M $5.85 Oct 28, 2024 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Common Stock 159K $6.28M $39.50 Nov 21, 2025 Indirect
Werewolf Therapeutics, Inc. Director, 10%+ Owner Common Stock 6.24M $6.11M $0.98 May 14, 2025 Indirect
Aerovate Therapeutics, Inc. 10%+ Owner Common Stock 1.29M $3.23M $2.51 Apr 28, 2025 Indirect
AN2 Therapeutics, Inc. 10%+ Owner Common Stock 301K $325K $1.08 Aug 9, 2024 Indirect
Aerovate Therapeutics, Inc. 10%+ Owner Stock Option (Right to Buy) 12.5K $205K $16.37 Jun 5, 2024 Indirect
Janux Therapeutics, Inc. Director, 10%+ Owner Common Stock 6.25K $160K $25.56 Jun 11, 2025 Indirect
Acumen Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 12.8K $14.1K $1.10 Jun 4, 2025 Indirect
89bio, Inc. Director, 10%+ Owner Common Stock 0 $0 $14.70 Oct 30, 2025 Indirect
Icosavax, Inc. Director, 10%+ Owner Common Stock 0 $0 $15.29 Feb 19, 2024 Indirect
Vor Biopharma Inc. Director, 10%+ Owner Warrant (Right to Buy) 21.1M Dec 30, 2024 Indirect
Fulcrum Therapeutics, Inc. 10%+ Owner Warrant (Right to Buy) 8.5M Aug 21, 2024 Indirect
4D Molecular Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants (Right to Buy) 3.61M Dec 9, 2024 Indirect
Artiva Biotherapeutics, Inc. Director, 10%+ Owner Common Stock 827K Jul 22, 2024 Indirect
Evommune, Inc. Director, 10%+ Owner Common Stock 784K Nov 7, 2025 Indirect
Boundless Bio, Inc. 10%+ Owner Common Stock 296K Apr 2, 2024 Indirect
Cidara Therapeutics, Inc. Director, 10%+ Owner Series A Preferred Stock 90K Jul 19, 2024 Indirect
Wave Life Sciences Ltd. Director, 10%+ Owner Share Option (Right to Buy) 76.2K Aug 11, 2025 Indirect
Vor Biopharma Inc. Director, 10%+ Owner Stock Option (Right to Buy) 60K Sep 8, 2025 Indirect
Nkarta, Inc. Director, 10%+ Owner Stock Option (right to buy) 46K Jun 5, 2025 Indirect
Climb Bio, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 40K Jun 4, 2025 Indirect
Mineralys Therapeutics, Inc. Director Stock Option (Right to Buy) 32.9K Feb 13, 2025 Indirect
ARS Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 30K Jun 25, 2025 Indirect
Bicara Therapeutics Inc. Director, 10%+ Owner Stock Option (Right to Buy) 23.7K Jun 9, 2025 Indirect
Tyra Biosciences, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 22.2K May 29, 2025 Indirect
Acrivon Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 20.3K Jun 13, 2025 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Non-Qualified Stock Option (right to buy) 20K Jun 12, 2025 Indirect
Acumen Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 19.5K Jun 4, 2025 Indirect
Werewolf Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 17.5K May 24, 2024 Indirect
Septerna, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 16.6K Jun 17, 2025 Indirect
PepGen Inc. Director, 10%+ Owner Stock Option (Right to Buy) 16K Jun 4, 2025 Indirect
Artiva Biotherapeutics, Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 13.8K Jun 24, 2025 Indirect
LENZ Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 13.5K Jun 11, 2025 Indirect
Janux Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 11.7K Jun 11, 2025 Indirect
Cidara Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 5.08K Jun 18, 2025 Indirect
89bio, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 0 Oct 30, 2025 Indirect
Artiva Biotherapeutics, Inc. Director, 10%+ Owner Series A Preferred Stock 0 Jul 22, 2024 Indirect
Artiva Biotherapeutics, Inc. Director, 10%+ Owner Series B Preferred Stock 0 Jul 22, 2024 Indirect
Bicara Therapeutics Inc. Director, 10%+ Owner Series B Preferred Stock 0 Sep 16, 2024 Indirect
Bicara Therapeutics Inc. Director, 10%+ Owner Series C Preferred Stock 0 Sep 16, 2024 Indirect
Boundless Bio, Inc. 10%+ Owner Series B Preferred Stock 0 Apr 2, 2024 Indirect
Boundless Bio, Inc. 10%+ Owner Series C Preferred Stock 0 Apr 2, 2024 Indirect
Cytek Biosciences, Inc. Director, 10%+ Owner Series D Preferred Stock 0 Jul 27, 2021 Indirect
DICE Therapeutics, Inc. Former 10% owners and Director Common Stock 0 $46.50 Aug 9, 2023 Indirect
DICE Therapeutics, Inc. Former 10% owners and Director Stock Option (Right to Buy) 0 Aug 9, 2023 Indirect
Evommune, Inc. Director, 10%+ Owner Series C Preferred Stock 0 Nov 7, 2025 Indirect
Forma Therapeutics Holdings, Inc. Director, 10%+ Owner Common Stock 0 $5.05 Oct 14, 2022 Indirect
Forma Therapeutics Holdings, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 0 Oct 14, 2022 Indirect
Icosavax, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 0 Feb 19, 2024 Indirect
Satsuma Pharmaceuticals, Inc. Former 10% Owner Common Stock 0 $0.91 Jun 8, 2023 Indirect
Satsuma Pharmaceuticals, Inc. Former 10% Owner Stock Option (Right to Buy) 0 Jun 8, 2023 Indirect
Septerna, Inc. Director, 10%+ Owner Series B Preferred Stock 0 Oct 28, 2024 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Series A Preferred Stock 0 Feb 10, 2025 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Series B Preferred Stock 0 Feb 10, 2025 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Series C Preferred Stock 0 Feb 10, 2025 Indirect
Sionna Therapeutics, Inc. Director, 10%+ Owner Series Seed Preferred Stock 0 Feb 10, 2025 Indirect

Insider Reports Filed by Ra Capital Management, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SION Sionna Therapeutics, Inc. Nov 20, 2025 12 -$1.2M 4 Nov 24, 2025 Director, 10%+ Owner
SION Sionna Therapeutics, Inc. Nov 17, 2025 24 -$5.5M 4 Nov 19, 2025 Director, 10%+ Owner
WVE Wave Life Sciences Ltd. Nov 13, 2025 1 $6.69K 4 Nov 14, 2025 Director, 10%+ Owner
EVMN Evommune, Inc. Nov 7, 2025 6 $20M 4 Nov 12, 2025 Director, 10%+ Owner
EVMN Evommune, Inc. Nov 5, 2025 0 $0 3 Nov 5, 2025 Director, 10%+ Owner
ETNB 89bio, Inc. Oct 30, 2025 10 $0 4 Nov 3, 2025 Director, 10%+ Owner
VOR Vor Biopharma Inc. Oct 28, 2025 4 -$10.4M 4 Oct 30, 2025 Director, 10%+ Owner
SION Sionna Therapeutics, Inc. Oct 24, 2025 8 -$14.8M 4 Oct 28, 2025 Director, 10%+ Owner
VOR Vor Biopharma Inc. Oct 23, 2025 3 -$6.2M 4 Oct 27, 2025 Director, 10%+ Owner
VOR Vor Biopharma Inc. Oct 20, 2025 5 -$3.43M 4 Oct 22, 2025 Director, 10%+ Owner
VOR Vor Biopharma Inc. Oct 15, 2025 16 -$13.7M 4 Oct 17, 2025 Director, 10%+ Owner
PEPG PepGen Inc. Sep 26, 2025 1 $30M 4 Sep 30, 2025 Director, 10%+ Owner
VOR Vor Biopharma Inc. Sep 18, 2025 1 $50M 4 Sep 22, 2025 Director, 10%+ Owner
VOR Vor Biopharma Inc. Sep 8, 2025 1 $0 4 Sep 10, 2025 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Sep 4, 2025 1 $30M 4 Sep 8, 2025 Director
WVE Wave Life Sciences Ltd. Aug 11, 2025 2 $0 4 Aug 13, 2025 Director, 10%+ Owner
CDTX Cidara Therapeutics, Inc. Jun 26, 2025 1 $100M 4 Jun 30, 2025 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Jun 25, 2025 1 $0 4 Jun 27, 2025 Director, 10%+ Owner
ARTV Artiva Biotherapeutics, Inc. Jun 24, 2025 1 $0 4 Jun 26, 2025 Director, 10%+ Owner
CDTX Cidara Therapeutics, Inc. Jun 18, 2025 1 $0 4 Jun 18, 2025 Director
SEPN Septerna, Inc. Jun 17, 2025 1 $0 4 Jun 20, 2025 Director, 10%+ Owner
ACRV Acrivon Therapeutics, Inc. Jun 13, 2025 1 $0 4 Jun 17, 2025 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. Jun 12, 2025 3 $1.66M 4 Jun 16, 2025 Director, 10%+ Owner
SION Sionna Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 16, 2025 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 11, 2025 2 $0 4 Jun 13, 2025 Director, 10%+ Owner
LENZ LENZ Therapeutics, Inc. Jun 11, 2025 1 $0 4 Jun 11, 2025 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. Jun 9, 2025 1 $1.9M 4 Jun 11, 2025 Director, 10%+ Owner
BCAX Bicara Therapeutics Inc. Jun 9, 2025 1 $0 4 Jun 10, 2025 Director, 10%+ Owner
NKTX Nkarta, Inc. Jun 5, 2025 1 $0 4 Jun 9, 2025 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. Jun 4, 2025 2 $11.8M 4 Jun 6, 2025 Director, 10%+ Owner
PEPG PepGen Inc. Jun 4, 2025 1 $0 4 Jun 6, 2025 Director, 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jun 4, 2025 2 $0 4 Jun 5, 2025 Director, 10%+ Owner
CLYM Climb Bio, Inc. Jun 4, 2025 1 $0 4 Jun 5, 2025 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. May 29, 2025 1 $0 4 Jun 2, 2025 Director, 10%+ Owner
VOR Vor Biopharma Inc. May 22, 2025 1 $0 4 May 23, 2025 Director, 10%+ Owner
HOWL Werewolf Therapeutics, Inc. May 12, 2025 3 $487K 4 May 14, 2025 Director, 10%+ Owner
JBIO Jade Biosciences, Inc. Apr 28, 2025 1 $0 4 Apr 30, 2025 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Mar 13, 2025 1 $17.5M 4 Mar 17, 2025 Director
JANX Janux Therapeutics, Inc. Mar 5, 2025 4 $25.3M 4 Mar 7, 2025 Director, 10%+ Owner
SLDB Solid Biosciences Inc. Feb 19, 2025 1 $15M 4 Feb 21, 2025 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 13, 2025 1 $0 4 Feb 24, 2025 Director
SION Sionna Therapeutics, Inc. Feb 10, 2025 16 $20.3M 4 Feb 10, 2025 Director, 10%+ Owner
SION Sionna Therapeutics, Inc. Feb 6, 2025 0 $0 3 Feb 6, 2025 Director, 10%+ Owner
ETNB 89bio, Inc. Feb 3, 2025 1 $0 4 Feb 5, 2025 Director, 10%+ Owner
ETNB 89bio, Inc. Jan 30, 2025 1 $50M 4 Feb 3, 2025 Director, 10%+ Owner
CDTX Cidara Therapeutics, Inc. Jan 3, 2025 1 $0 4 Jan 7, 2025 Director
VOR Vor Biopharma Inc. Dec 30, 2024 2 $0 4 Dec 30, 2024 Director, 10%+ Owner
FDMT 4D Molecular Therapeutics, Inc. Dec 9, 2024 2 $0 4 Dec 10, 2024 10%+ Owner
CDTX Cidara Therapeutics, Inc. Nov 26, 2024 2 $25M 4 Nov 29, 2024 Director
ETNB 89bio, Inc. Nov 14, 2024 1 $27.6M 4 Nov 18, 2024 Director, 10%+ Owner
FDMT 4D Molecular Therapeutics, Inc. Nov 13, 2024 0 $0 3 Nov 25, 2024 10%+ Owner
TYRA Tyra Biosciences, Inc. Nov 8, 2024 1 $19.8M 4 Nov 13, 2024 Director, 10%+ Owner
SEPN Septerna, Inc. Oct 28, 2024 6 $75.1M 4 Oct 30, 2024 Director, 10%+ Owner
SEPN Septerna, Inc. Oct 24, 2024 0 $0 3 Oct 24, 2024 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. Oct 18, 2024 2 $0 4 Oct 22, 2024 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Oct 18, 2024 1 $53.7M 4 Oct 22, 2024 Director, 10%+ Owner
BCAX Bicara Therapeutics Inc. Sep 16, 2024 8 $33M 4 Sep 18, 2024 Director, 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Sep 12, 2024 0 $0 3 Sep 23, 2024 10%+ Owner
BCAX Bicara Therapeutics Inc. Sep 12, 2024 1 $0 4 Sep 16, 2024 Director, 10%+ Owner
BCAX Bicara Therapeutics Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director, 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Aug 21, 2024 2 $0 4 Aug 23, 2024 10%+ Owner
WVE Wave Life Sciences Ltd. Aug 12, 2024 2 $0 4 Aug 14, 2024 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 9, 2024 2 -$3.81M 4 Aug 13, 2024 10%+ Owner
ARTV Artiva Biotherapeutics, Inc. Jul 22, 2024 12 $105M 4 Jul 24, 2024 Director, 10%+ Owner
CDTX Cidara Therapeutics, Inc. Jul 18, 2024 3 $100M 4 Jul 22, 2024 Director
CDTX Cidara Therapeutics, Inc. Jul 18, 2024 1 $0 4/A Jul 22, 2024 Director
CDTX Cidara Therapeutics, Inc. Jul 18, 2024 1 $0 4 Jul 19, 2024 Director
ARTV Artiva Biotherapeutics, Inc. Jul 18, 2024 0 $0 3 Jul 18, 2024 Director, 10%+ Owner
ELYM Eliem Therapeutics, Inc. Jun 27, 2024 5 $50M 4 Jul 1, 2024 Director, 10%+ Owner
ELYM Eliem Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 28, 2024 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 26, 2024 2 $0 4 Jun 28, 2024 Director, 10%+ Owner
ACRV Acrivon Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director, 10%+ Owner
PEPG PepGen Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director, 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Jun 17, 2024 1 $1.55M 4 Jun 20, 2024 Director, 10%+ Owner
NKTX Nkarta, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director, 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jun 10, 2024 1 $0 4 Jun 10, 2024 Director, 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. May 29, 2024 1 $0 4 May 31, 2024 Director, 10%+ Owner
HOWL Werewolf Therapeutics, Inc. May 24, 2024 1 $0 4 May 24, 2024 Director, 10%+ Owner
VOR Vor Biopharma Inc. May 23, 2024 1 $0 4 May 28, 2024 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. May 22, 2024 1 $0 4 May 28, 2024 Director
ITOS iTeos Therapeutics, Inc. May 10, 2024 3 $100M 4 May 14, 2024 Former 10% Owner
CDTX Cidara Therapeutics, Inc. Apr 26, 2024 1 $0 4 Apr 30, 2024 Director
CDTX Cidara Therapeutics, Inc. Apr 24, 2024 0 $0 3 Apr 30, 2024 Director
ACRV Acrivon Therapeutics, Inc. Apr 11, 2024 1 $30M 4 Apr 15, 2024 Director, 10%+ Owner
BOLD Boundless Bio, Inc. Apr 2, 2024 8 $5M 4 Apr 4, 2024 10%+ Owner
NKTX Nkarta, Inc. Mar 27, 2024 2 $60M 4 Mar 29, 2024 Director, 10%+ Owner
BOLD Boundless Bio, Inc. Mar 27, 2024 0 $0 3 Mar 27, 2024 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Mar 25, 2024 3 $13.3M 4 Mar 27, 2024 Director, 10%+ Owner
LENZ LENZ Therapeutics, Inc. Mar 21, 2024 9 $15M 4 Mar 25, 2024 Director, 10%+ Owner
LENZ LENZ Therapeutics, Inc. Mar 21, 2024 0 $0 3 Mar 25, 2024 Director
ETNB 89bio, Inc. Mar 4, 2024 1 $20.7M 4 Mar 6, 2024 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Mar 4, 2024 1 $65M 4 Mar 6, 2024 Director, 10%+ Owner
ICVX Icosavax, Inc. Feb 19, 2024 5 $0 4 Feb 20, 2024 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 12, 2024 2 $30M 4 Feb 14, 2024 Director
PEPG PepGen Inc. Feb 9, 2024 1 $27.2M 4 Feb 13, 2024 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. Feb 6, 2024 2 $61.4M 4 Feb 8, 2024 Director, 10%+ Owner
SLDB Solid Biosciences Inc. Jan 11, 2024 1 $5M 4 Jan 12, 2024 Director, 10%+ Owner
WVE Wave Life Sciences Ltd. Dec 11, 2023 1 $5M 4/A Jan 17, 2024 Director, 10%+ Owner
WVE Wave Life Sciences Ltd. Dec 11, 2023 1 $5M 4 Dec 13, 2023 Director, 10%+ Owner
ETNB 89bio, Inc. Dec 11, 2023 1 $10M 4 Dec 13, 2023 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Sep 21, 2023 2 $8.18M 4 Sep 25, 2023 Director
SPRY ARS Pharmaceuticals, Inc. Aug 29, 2023 1 $23.3M 4 Aug 31, 2023 Director
ANTX AN2 Therapeutics, Inc. Aug 18, 2023 1 $16M 4 Aug 22, 2023 10%+ Owner
DICE DICE Therapeutics, Inc. Aug 9, 2023 3 $0 4 Aug 9, 2023 Former 10% owners and Director
WVE Wave Life Sciences Ltd. Aug 7, 2023 1 $0 4 Aug 9, 2023 Director, 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jul 21, 2023 1 $40M 4 Jul 25, 2023 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jul 19, 2023 2 $12.4M 4 Jul 21, 2023 Director, 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Jul 5, 2023 1 $4.68M 4 Jul 7, 2023 Director
SPRY ARS Pharmaceuticals, Inc. Jun 27, 2023 1 $0 4 Jun 28, 2023 Director
HOWL Werewolf Therapeutics, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director, 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Jun 8, 2023 4 $0 4 Jun 12, 2023 Former 10% Owner
NKTX Nkarta, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director, 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jun 6, 2023 1 $0 4 Jun 13, 2023 Director, 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director, 10%+ Owner
SLDB Solid Biosciences Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director, 10%+ Owner
ICVX Icosavax, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director, 10%+ Owner
VOR Vor Biopharma Inc. May 26, 2023 1 $0 4 Jun 2, 2023 Director, 10%+ Owner
ELYM Eliem Therapeutics, Inc. May 18, 2023 1 $0 4 May 22, 2023 Director, 10%+ Owner
DICE DICE Therapeutics, Inc. Mar 28, 2023 3 $14.8M 4 Mar 30, 2023 Director, 10%+ Owner
ETNB 89bio, Inc. Mar 24, 2023 1 $40M 4 Mar 30, 2023 Director, 10%+ Owner
DICE DICE Therapeutics, Inc. Mar 23, 2023 3 $13.5M 4 Mar 27, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Feb 27, 2023 Former 10% owner
MLYS Mineralys Therapeutics, Inc. Feb 14, 2023 6 $20M 4 Feb 16, 2023 Director
ETNB 89bio, Inc. Feb 9, 2023 4 $7.5M 4 Apr 15, 2024 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 0 $0 3 Feb 9, 2023 Director, 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Jan 20, 2023 1 $25M 4 Jan 24, 2023 10%+ Owner
HOWL Werewolf Therapeutics, Inc. Jan 6, 2023 1 $4.1M 4 Jan 10, 2023 Director, 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Jan 4, 2023 2 $1.31M 4 Jan 6, 2023 10%+ Owner
ELVN IMARA Inc. Jan 3, 2023 1 $2.52M 4 Jan 5, 2023 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Dec 27, 2022 1 $24.5K 4 Dec 29, 2022 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Dec 19, 2022 1 $583K 4 Dec 21, 2022 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Dec 14, 2022 3 $13.1M 4 Dec 16, 2022 10%+ Owner
SLDB Solid Biosciences Inc. Dec 13, 2022 1 $0 4 Dec 15, 2022 Director, 10%+ Owner
VOR Vor Biopharma Inc. Dec 9, 2022 1 $50M 4 Dec 9, 2022 Director, 10%+ Owner
ELVN IMARA Inc. Dec 8, 2022 2 $116K 4 Dec 12, 2022 10%+ Owner
SLDB Solid Biosciences Inc. Dec 2, 2022 3 $15.2M 4 Dec 5, 2022 Director, 10%+ Owner
ACRV Acrivon Therapeutics, Inc. Nov 17, 2022 5 $42.4M 4 Nov 21, 2022 Director, 10%+ Owner
ACRV Acrivon Therapeutics, Inc. Nov 14, 2022 1 $0 4 Nov 16, 2022 Director, 10%+ Owner
ACRV Acrivon Therapeutics, Inc. Nov 9, 2022 0 $0 3 Nov 9, 2022 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 2 $0 4 Nov 10, 2022 Director
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 0 $0 3 Nov 10, 2022 Director
ELVN IMARA Inc. Oct 20, 2022 3 $337K 4 Oct 24, 2022 10%+ Owner
ETNB 89bio, Inc. Oct 18, 2022 1 $8.97M 4 Oct 20, 2022 Director, 10%+ Owner
ELVN IMARA Inc. Oct 17, 2022 3 $1.86M 4 Oct 19, 2022 10%+ Owner
DICE DICE Therapeutics, Inc. Oct 17, 2022 1 $59.9M 4 Oct 19, 2022 Director, 10%+ Owner
ELVN IMARA Inc. Oct 17, 2022 0 $0 3 Oct 19, 2022 10%+ Owner
FMTX Forma Therapeutics Holdings, Inc. Oct 14, 2022 6 $0 4 Oct 14, 2022 Director, 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Aug 16, 2022 0 $0 3 Aug 26, 2022 10%+ Owner
WVE Wave Life Sciences Ltd. Aug 15, 2022 1 $0 4 Aug 17, 2022 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 3, 2022 2 $14.3K 4 Aug 5, 2022 10%+ Owner
ANTX AN2 Therapeutics, Inc. Jul 26, 2022 2 $181K 4 Jul 28, 2022 10%+ Owner
ETNB 89bio, Inc. Jul 1, 2022 2 $10M 4 Jul 6, 2022 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Jun 21, 2022 1 $2.41K 4 Jun 23, 2022 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director, 10%+ Owner
WVE Wave Life Sciences Ltd. Jun 16, 2022 2 $35.6M 4 Jun 21, 2022 Director, 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jun 15, 2022 1 $0 4 Jun 21, 2022 Director, 10%+ Owner
VOR Vor Biopharma Inc. Jun 14, 2022 1 $0 4 Jun 17, 2022 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Jun 13, 2022 2 $647K 4 Jun 15, 2022 10%+ Owner
ICVX Icosavax, Inc. Jun 10, 2022 2 $0 4 Jun 14, 2022 Director, 10%+ Owner
ITOS iTeos Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director, 10%+ Owner
NKTX Nkarta, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director, 10%+ Owner
FTMX Forma Therapeutics Holdings, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director, 10%+ Owner
SLDB Solid Biosciences Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Director, 10%+ Owner
DICE DICE Therapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 8, 2022 Director, 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Jun 3, 2022 1 $0 4 Jun 7, 2022 Director, 10%+ Owner
HOWL Werewolf Therapeutics, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director, 10%+ Owner
KALA Kala Pharmaceuticals, Inc. May 26, 2022 1 -$366K 4 May 26, 2022 10%+ Owner
KALA Kala Pharmaceuticals, Inc. May 23, 2022 3 -$1.49M 4 May 25, 2022 10%+ Owner
ELYM Eliem Therapeutics, Inc. May 19, 2022 1 $0 4 Jun 1, 2022 Director, 10%+ Owner
ETNB 89bio, Inc. May 16, 2022 1 $0 4 Jun 2, 2022 Director, 10%+ Owner
PEPG PepGen Inc. May 10, 2022 10 $38.8M 4 May 12, 2022 Director, 10%+ Owner
PEPG PepGen Inc. May 6, 2022 1 $0 4 May 10, 2022 Director, 10%+ Owner
PEPG PepGen Inc. May 5, 2022 0 $0 3/A May 12, 2022 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Mar 29, 2022 6 $25M 4 Mar 31, 2022 10%+ Owner
ICVX Icosavax, Inc. Mar 28, 2022 2 $837K 4 Mar 30, 2022 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 10%+ Owner
CTKB Cytek Biosciences, Inc. Mar 14, 2022 2 $7.19M 4 Mar 16, 2022 Director, 10%+ Owner
CTKB Cytek Biosciences, Inc. Mar 9, 2022 3 $8.16M 4 Mar 11, 2022 Director
CTKB Cytek Biosciences, Inc. Mar 4, 2022 3 $8.25M 4 Mar 8, 2022 Director
CTKB Cytek Biosciences, Inc. Feb 28, 2022 3 $5.72M 4 Mar 2, 2022 Director
CTKB Cytek Biosciences, Inc. Feb 23, 2022 3 $5.56M 4 Feb 25, 2022 Director
CTKB Cytek Biosciences, Inc. Feb 17, 2022 3 $7.7M 4 Feb 22, 2022 Director
NKTX Nkarta, Inc. Feb 14, 2022 1 $33M 4 Apr 28, 2022 Director, 10%+ Owner
CTKB Cytek Biosciences, Inc. Feb 14, 2022 3 $7.43M 4 Feb 16, 2022 Director
DICE DICE Therapeutics, Inc. Sep 17, 2021 8 $23.8M 4 Sep 20, 2021 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. Sep 17, 2021 9 $20M 4 Sep 17, 2021 Director, 10%+ Owner
DICE DICE Therapeutics, Inc. Sep 14, 2021 0 $0 3 Sep 14, 2021 Director, 10%+ Owner
TYRA Tyra Biosciences, Inc. Sep 14, 2021 0 $0 3 Sep 14, 2021 Director, 10%+ Owner
WVE Wave Life Sciences Ltd. Aug 16, 2021 1 $0 4 Aug 18, 2021 Director, 10%+ Owner
ELYM Eliem Therapeutics, Inc. Aug 12, 2021 14 $40M 4 Aug 16, 2021 Director, 10%+ Owner
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 1 $0 4 Aug 11, 2021 Director, 10%+ Owner
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 0 $0 3 Aug 9, 2021 Director, 10%+ Owner
RXST RxSight, Inc. Aug 3, 2021 0 $0 3 Aug 13, 2021 10%+ Owner
ICVX Icosavax, Inc. Aug 2, 2021 6 $40M 4 Aug 4, 2021 Director, 10%+ Owner
ICVX Icosavax, Inc. Jul 28, 2021 0 $0 3 Jul 28, 2021 Director, 10%+ Owner
CTKB Cytek Biosciences, Inc. Jul 27, 2021 8 $50.2M 4 Jul 29, 2021 Director
CTKB Cytek BioSciences, Inc. Jul 22, 2021 0 $0 3 Jul 22, 2021 Director
ABOS Acumen Pharmaceuticals, Inc. Jul 6, 2021 8 $30M 4 Jul 8, 2021 Director, 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Jul 2, 2021 8 $39M 4 Jul 6, 2021 Director, 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 0 $0 3 Jun 30, 2021 Director, 10%+ Owner
PNT Therapeutics Acquisition Corp. Jun 29, 2021 1 $2.09M 4 Jun 30, 2021 Director
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 Director, 10%+ Owner
PNT Therapeutics Acquisition Corp. Jun 23, 2021 0 $0 3 Jun 24, 2021 Director
JANX Janux Therapeutics, Inc. Jun 15, 2021 10 $50M 4 Jun 16, 2021 Director, 10%+ Owner
HOWL Werewolf Therapeutics, Inc. Jun 14, 2021 3 $4.13M 4 Jun 16, 2021 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 10, 2021 0 $0 3 Jun 10, 2021 Director, 10%+ Owner
ETNB 89bio, Inc. Jun 2, 2021 1 $416K 4 Jun 4, 2021 Director, 10%+ Owner
ETNB 89bio, Inc. May 26, 2021 3 $3.86M 4 May 28, 2021 Director, 10%+ Owner